296 related articles for article (PubMed ID: 24811343)
1. FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.
Sehgal L; Mathur R; Braun FK; Wise JF; Berkova Z; Neelapu S; Kwak LW; Samaniego F
Leukemia; 2014 Dec; 28(12):2376-87. PubMed ID: 24811343
[TBL] [Abstract][Full Text] [Related]
2. RBM5/Luca-15/H37 regulates Fas alternative splice site pairing after exon definition.
Bonnal S; Martínez C; Förch P; Bachi A; Wilm M; Valcárcel J
Mol Cell; 2008 Oct; 32(1):81-95. PubMed ID: 18851835
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced lncRNA RBM5-AS1 promotes tumorigenesis via activating Wnt/β-catenin signaling in breast cancer.
Li X; Yang J; Ni R; Chen J; Zhou Y; Song H; Jin L; Pan Y
Cell Death Dis; 2022 Feb; 13(2):95. PubMed ID: 35110544
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells.
Liu J; Pan C; Lu R; Zhang S
Bioengineered; 2022 Mar; 13(3):7868-7880. PubMed ID: 35291911
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterisation of a novel antisense non-coding RNA from the RBM5 gene locus.
Rintala-Maki ND; Sutherland LC
Gene; 2009 Sep; 445(1-2):7-16. PubMed ID: 19559772
[TBL] [Abstract][Full Text] [Related]
7. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.
Ye Y; Yang S; Han Y; Sun J; Xv L; Wu L; Ming L
Open Biol; 2019 Sep; 9(9):190068. PubMed ID: 31551012
[TBL] [Abstract][Full Text] [Related]
8. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
9. RBM5-AS1 Is Critical for Self-Renewal of Colon Cancer Stem-like Cells.
Di Cecilia S; Zhang F; Sancho A; Li S; Aguiló F; Sun Y; Rengasamy M; Zhang W; Del Vecchio L; Salvatore F; Walsh MJ
Cancer Res; 2016 Oct; 76(19):5615-5627. PubMed ID: 27520449
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.
Wang X; Sehgal L; Jain N; Khashab T; Mathur R; Samaniego F
J Transl Med; 2016 Dec; 14(1):346. PubMed ID: 27998273
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA AFAP1-AS1 accelerates the proliferation and metastasis of prostate cancer via inhibiting RBM5 expression.
Yang ZT; An F; Hu JD; Zhao WH
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3284-3290. PubMed ID: 31081081
[TBL] [Abstract][Full Text] [Related]
13. [Expression of FAS-AS1 in breast cancer and its effect on the host gene sFas].
Zhou SW; Su BB; Zhou Y
Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(12):949-53. PubMed ID: 27045720
[TBL] [Abstract][Full Text] [Related]
14. The oncogenic role of LncRNA FAM83C-AS1 in colorectal cancer development by epigenetically inhibits SEMA3F via stabilizing EZH2.
Xue W; Wang F; Han P; Liu Y; Zhang B; Gu X; Wang Y; Li M; Zhao Y; Cui B
Aging (Albany NY); 2020 Oct; 12(20):20396-20412. PubMed ID: 33109776
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis.
Villamizar O; Chambers CB; Riberdy JM; Persons DA; Wilber A
Oncotarget; 2016 Mar; 7(12):13810-26. PubMed ID: 26885613
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells.
Kikuchi J; Takashina T; Kinoshita I; Kikuchi E; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Marquez VE; Nishimura M; Dosaka-Akita H
Lung Cancer; 2012 Nov; 78(2):138-43. PubMed ID: 22925699
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA MRPL23-AS1 Promotes Adenoid Cystic Carcinoma Lung Metastasis.
Chen CW; Fu M; Du ZH; Zhao F; Yang WW; Xu LH; Li SL; Ge XY
Cancer Res; 2020 Jun; 80(11):2273-2285. PubMed ID: 32098781
[TBL] [Abstract][Full Text] [Related]
18. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
19. LncRNA STXBP5-AS1 suppresses stem cell-like properties of pancreatic cancer by epigenetically inhibiting neighboring androglobin gene expression.
Chen S; Huang L; Li G; Qiu F; Wang Y; Yang C; Pan J; Wu Z; Chen J; Tian Y
Clin Epigenetics; 2020 Nov; 12(1):168. PubMed ID: 33160411
[TBL] [Abstract][Full Text] [Related]
20. The EZH2-PHACTR2-AS1-Ribosome Axis induces Genomic Instability and Promotes Growth and Metastasis in Breast Cancer.
Chu W; Zhang X; Qi L; Fu Y; Wang P; Zhao W; Du J; Zhang J; Zhan J; Wang Y; Zhu WG; Yu Y; Zhang H
Cancer Res; 2020 Jul; 80(13):2737-2750. PubMed ID: 32312833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
